| 
									
										| 
												
													
													| 
															
				
															
															
															
					| HIV: Antiretroviral Therapy (ART)
		
			| HIV: Antiretroviral Therapy (ART)Skip to the navigationTopic OverviewAntiretroviral therapy (ART) is the
		combination of several antiretroviral medicines used to slow the rate at which
		HIV makes copies of itself (multiplies) in the body. A
		combination of three or more antiretroviral medicines is more effective than
		using just one medicine (monotherapy) to treat HIV. The use of
		three or more antiretroviral medicines-sometimes referred to as an anti-HIV
		"cocktail"-is currently the standard treatment for HIV infection. So far, this
		treatment offers the best chance of preventing HIV from multiplying, which
		allows your
		immune system to stay healthy. The goal of
		antiretroviral therapy is to reduce the amount of virus in your body (viral
		load) to a level that can no longer be detected with current blood
		tests. Antiretroviral medicines that are often used to treat HIV
		include: Nucleoside/nucleotide reverse transcriptase
		  inhibitors, also called nucleoside analogs, such as abacavir, emtricitabine,
		  and tenofovir. These medicines are often combined for best
		  results.Nonnucleoside reverse transcriptase inhibitors (NNRTIs),
		  such as efavirenz, etravirine, and nevirapine.Protease inhibitors
		  (PIs), such as atazanavir,  darunavir, and ritonavir.Entry inhibitors, such as enfuvirtide and maraviroc.Integrase
		  inhibitors, such as dolutegravir    and raltegravir.
 Some medicines are available combined together in one pill.
		This reduces the number of pills to be taken each day. The U.S. National Institutes of Health recommends using one of the following programs for people who begin treatment for HIV:footnote 1 Dolutegravir + abacavir + lamivudineDolutegravir + tenofovir + emtricitabineElvitegravir + cobicistat + tenofovir + emtricitabineRaltegravir + tenofovir + emtricitabineRitonavir-boosted darunavir + tenofovir + emtricitabine
 Other drug combinations are approved and may be used in some cases. Also, studies have shown that if you are not infected with HIV, taking antiretroviral medicines can protect you against HIV.footnote 2, footnote 3 But to keep your risk low, you still need to use safer sex practices.ReferencesCitationsU.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents (2015). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. U.S. Department of Health and Human Services. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed May 5, 2015.Grant RM, et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27): 2588-2599.Baeten JM, et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5): 399-410.
CreditsByHealthwise StaffPrimary Medical ReviewerE. Gregory Thompson, MD - Internal Medicine
 Adam Husney, MD - Family Medicine
 Specialist Medical ReviewerPeter Shalit, MD, PhD - Internal Medicine
Current as ofMarch 3, 2017Current as of:
                March 3, 2017U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents (2015). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. U.S. Department of Health and Human Services. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed May 5, 2015. Grant RM, et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27): 2588-2599. Baeten JM, et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5): 399-410. Last modified on: 8 September 2017  |  |  |  |  |  |